iShares US Pharmaceuticals ETF
IHE
IHE
91 hedge funds and large institutions have $205M invested in iShares US Pharmaceuticals ETF in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 47 reducing their positions, and 23 closing their positions.
Holders
91
Holders Change
-12
Holders Change %
-11.65%
% of All Funds
2.43%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
11
Increased
13
Reduced
47
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
Morgan Stanley
New York
|
$19.5M |
2 |
2
Goldman Sachs
New York
|
$13.8M |
3 |
3
Wells Fargo
San Francisco,
California
|
$7.14M |
4 |
4
Bank of America
Charlotte,
North Carolina
|
$22.4M |
5 |
5
LPL Financial
San Diego,
California
|
$11.9M |